Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

Acute myeloid leukemia (AML) continues to be extremely difficult to treat successfully, and the unacceptably low overall survival rates mandate that we assess new potential therapies to ameliorate poor clinical response to conventional therapy. Abnormal tyrosine kinase activation in AML has been ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee-Sherick, A B, Eisenman, K M, Sather, S, McGranahan, A, Armistead, P M, McGary, C S, Hunsucker, S A, Schlegel, J, Martinson, H, Cannon, C, Keating, A K, Earp, H S, Liang, X, DeRyckere, D, Graham, D K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898106/
https://www.ncbi.nlm.nih.gov/pubmed/23474756
http://dx.doi.org/10.1038/onc.2013.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898106/
https://www.ncbi.nlm.nih.gov/pubmed/23474756
http://dx.doi.org/10.1038/onc.2013.40

Ejemplares similares